PDE5 inhibitors are the most widely prescribed class of medicines for erectile dysfunction (ED), and understanding how they work can help men have more informed conversations with their doctors before starting treatment. Since sildenafil became the first approved medicine in this class in 1998, the group has expanded to include tadalafil, vardenafil, and avanafil, each sharing the same fundamental mechanism while differing in duration of effect and onset time.
This article explains the biological mechanism behind sildenafil and tadalafil, how these two options compare on key clinical factors, and what safety considerations a prescribing clinician will assess before making a recommendation.
Table of Contents
ToggleWhat Are PDE5 Inhibitors?
Phosphodiesterase type 5 inhibitors, commonly called PDE5 inhibitors, are prescription medicines that act on a specific enzyme found in the smooth muscle cells lining blood vessels in the penis. The class currently includes four medicines approved for ED: sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra), and avanafil (Stendra). While all four target the same enzyme, each has a distinct clinical profile in terms of how quickly it takes effect and how long those effects may last.
According to the NHS erection problems guide, these medicines are generally the first medical option a GP will consider for men with ED, provided there are no contraindications. Because they require a prescription, a clinical consultation is essential, giving the doctor an opportunity to assess the underlying cause of ED and review any other medicines the patient is already taking.
The Mechanism Behind PDE5 Inhibitors and Blood Flow
Achieving an erection relies on a sequence of chemical signals. When sexual stimulation occurs, nerves release nitric oxide into penile tissue, which prompts the production of a signalling molecule called cyclic guanosine monophosphate, or cGMP. This molecule relaxes the smooth muscle within the walls of penile arteries, allowing those vessels to widen and fill with blood, which is what produces and sustains an erection.
Under ordinary circumstances, the PDE5 enzyme breaks down cGMP, limiting how long this relaxation continues. PDE5 inhibitors block that enzyme, allowing cGMP to accumulate and smooth muscle relaxation to persist for longer. A PMC erectile dysfunction review notes that the PDE5 signalling pathway plays a central role in penile vascular function, and that inhibiting this enzyme may improve erectile response for many men with vasculogenic or mixed-cause ED.
Importantly, this process still requires sexual stimulation to begin. Without arousal-triggered nitric oxide release, cGMP does not accumulate and the medicine cannot exert its effect. This is a common point of confusion addressed in the FAQ section below.
Sildenafil vs Tadalafil: Duration, Onset, and Dosing
Although sildenafil and tadalafil share the same mechanism, several differences in their pharmacological profiles may influence which a doctor recommends for a particular patient.
Sildenafil is typically taken 30 to 60 minutes before sexual activity. According to Mayo Clinic ED treatment guidance, sildenafil may remain effective for approximately 4 to 6 hours. Because high-fat meals can delay its absorption and reduce peak blood concentrations, many prescribers recommend taking it on an empty stomach or after a light meal. It is available in doses of 25 mg, 50 mg, and 100 mg, and a doctor will usually recommend beginning at the lowest effective dose.
Tadalafil has a considerably longer duration of action. Mayo Clinic notes that tadalafil may last up to 36 hours in some men, which provides greater flexibility around the timing of sexual activity. Food does not meaningfully affect tadalafil’s absorption. It is also available in a low-dose daily formulation, which some men and their doctors prefer because it removes the need to plan dosing around a specific window. The choice between these two medicines depends on personal lifestyle, frequency of sexual activity, individual tolerability, and any co-existing health conditions.
Who Should Avoid PDE5 Inhibitors
PDE5 inhibitors are not suitable for all men, and a careful medical assessment is required before starting any medicine in this class.
The most critical contraindication is concurrent use of nitrate medicines. Nitrates, which include glyceryl trinitrate (GTN) sprays, isosorbide tablets, and certain recreational drugs such as amyl nitrite, are commonly prescribed for angina and some other cardiac conditions. The AUA erectile dysfunction guideline states that combining any PDE5 inhibitor with a nitrate preparation can cause a severe and potentially life-threatening fall in blood pressure, making this combination absolutely contraindicated in clinical practice.
Other circumstances that may preclude use include uncontrolled low blood pressure, a recent heart attack or stroke (typically within the past six months), severe liver impairment, and certain inherited retinal disorders. Caution is also warranted in men taking alpha-blocker medicines for high blood pressure or benign prostatic hyperplasia, since the combination can lower blood pressure more than either agent alone. A prescribing clinician should review all current medicines, including over-the-counter products and herbal supplements, before recommending any of these medicines.
Side Effects and Safety Considerations
Like all prescription medicines, PDE5 inhibitors can cause side effects, and the pattern and severity vary between individuals. According to Mayo Clinic’s ED treatment guidance, commonly reported effects include headache, facial flushing, nasal congestion, and indigestion. Sildenafil may also cause temporary visual changes in some men, such as a blue tinge to vision or heightened sensitivity to light, due to mild activity on a related retinal enzyme.
Rarer but more serious effects include priapism, a prolonged and painful erection lasting more than four hours that requires emergency medical attention, and sudden changes in vision or hearing. The NHS notes that any man who experiences these symptoms should seek immediate care.
There is also an important broader health context. Mayo Clinic notes that ED can be an early indicator of cardiovascular disease, as the narrowing of blood vessels affecting penile circulation may reflect a wider pattern of arterial disease across the body. The CDC heart disease risk factors page identifies high blood pressure, high cholesterol, smoking, and type 2 diabetes as major cardiovascular contributors, all of which are also independently associated with ED. A new diagnosis of ED therefore warrants a comprehensive health review rather than simply a prescription.
Frequently Asked Questions
How quickly do PDE5 inhibitors take effect?
Onset time differs between medicines and individuals. According to Mayo Clinic’s ED treatment guidance, sildenafil may begin to work within 30 to 60 minutes, while tadalafil may take anywhere from 30 minutes to two hours to reach peak effect. Eating a large, high-fat meal before taking sildenafil can delay its absorption noticeably. A prescribing doctor can advise on optimal timing based on the specific medicine chosen and any relevant dietary or lifestyle factors.
Can I take PDE5 inhibitors alongside other medications?
Not always safely. As described above, combining these medicines with nitrates in any form is contraindicated due to the risk of a severe blood pressure drop. Caution is also required with alpha-blocker medicines, certain antifungal treatments such as ketoconazole, and some antiretroviral medicines used in HIV management, which can raise blood levels of sildenafil or tadalafil to a potentially unsafe degree. The NHS recommends disclosing all prescription medicines, over-the-counter products, supplements, and herbal remedies to your doctor before starting any treatment for ED, so that interactions can be properly assessed.
Are PDE5 inhibitors safe for men with heart disease?
This depends on the type and severity of the condition. For men with stable, well-managed cardiovascular disease who are not taking nitrates, a cardiologist or GP may consider one of these medicines appropriate after a thorough assessment. For men with unstable angina, a recent heart attack, uncontrolled heart failure, or severely reduced cardiac reserve, the AUA guideline recommends obtaining cardiology clearance before any ED medicine is started. The PMC review on ED and cardiovascular disease notes that the two conditions share overlapping vascular risk factors and biological mechanisms, reinforcing why a full cardiac evaluation forms an integral part of any ED consultation.
Do PDE5 inhibitors work without sexual stimulation?
No. These medicines enhance the body’s normal vascular response to sexual arousal rather than independently initiating an erection. Without arousal-triggered nitric oxide release, the cGMP pathway is not activated, and smooth muscle relaxation in the penile arteries does not occur. Men beginning treatment for the first time should understand that the medicine works alongside the natural process of becoming aroused, not instead of it. If an erection does not occur despite taking the medicine correctly and being appropriately stimulated, a doctor can investigate whether a dose adjustment or a different approach may help.
When to See a Doctor
Talk to your doctor before you start, stop, or change any treatment, and if symptoms are new, persistent, or getting worse. Seek emergency care right away if you have chest pain, fainting or severe dizziness, an erection lasting more than 4 hours (priapism), or any thoughts of suicide.
By Editorial Team
Reviewed against medical sources on 2026-09-18.
Info Men’s Health is an independent education site; our Editorial Team reviews every article against primary medical sources. This is not medical advice.
Medical disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified clinician about your individual situation.
Sources
- NHS: causes, treatments and when to see a GP for erection problems
- Mayo Clinic: ED symptoms, causes and the link to heart disease
- Mayo Clinic: ED diagnosis and treatment options
- CDC: cardiovascular risk factors
- PMC review: erectile dysfunction and cardiovascular disease
- American Urological Association: ED clinical guideline